Clinical Trial Detail

NCT ID NCT01903733
Title Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

chronic myeloid leukemia

Therapies

Bosutinib

Age Groups: adult

No variant requirements are available.